GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS)
$0.025 -0.005 (-16.6667%)
Analysed GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) News Sources
Arecor Therapeutics, Great Southern Copper, Powerhouse Energy, Genflow Biosciences, Gelion
13-04-2026
yahoo.com
Genflow Biosciences expands SIRT6 patent protection into muscular diseases
13-04-2026
proactiveinvestors.com
Genflow Biosciences PLC Announces International Patent Publication
13-04-2026
yahoo.com
Genflow CEO on promising SLAB trial data - ICYMI
11-04-2026
proactiveinvestors.com
Genflow reports sustained safety and efficacy three months after gene therapy dosing in dog trial
08-04-2026
proactiveinvestors.com
Genflow Biosciences PLC Announces Total Voting Rights
31-03-2026
yahoo.com
Genflow Biosciences PLC Announces Issue of Equity & PDMR Notifications
05-03-2026
yahoo.com
Genflow Biosciences raises £800,000 to fund gene therapy programmes
05-03-2026
proactiveinvestors.com
Genflow Biosciences PLC Announces Result of GM
02-03-2026
yahoo.com
Genflow Biosciences confirms receipt of €4m grant installment
02-03-2026
proactiveinvestors.com
What is the current price of GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS)?
The current price of GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) is $0.025.
GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) since the previous trading day is $-0.005.
GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) since the previous trading day is -16.6667%.
What is the most recent average sentiment score for GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS)?
The most recent average sentiment score for GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) is 78 out of 100.
What is the most recent average sentiment for GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS)?
The most recent sentiment for GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS) is .
SEC-8K** Filing Available For GENFLOW BIOSCIENCES PLC (GENFF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.